Recombinant multi-species KCNIP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KCNIP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the family of voltage-gated potassium (Kv) channel-interacting proteins (KCNIPs), which belongs to the recoverin branch of the EF-hand superfamily. Members of the KCNIP family are small calcium binding proteins. They all have EF-hand-like domains, and differ from each other in the N-terminus. They are integral subunit components of native Kv4 channel complexes. They may regulate A-type currents, and hence neuronal excitability, in response to changes in intracellular calcium. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified from this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: A-type potassium channel modulatory protein KCNIP2,Cardiac voltage-gated potassium channel modulatory subunit,KCHIP2,KCNIP2,KChIP2,Kchip2,Kcnip2,Kv channel-interacting protein 2 (KChIP2),Potassium channel-interacting protein 2

Target products collectionGo to KCNIP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7921-Ag-1/ GM-Tg-hg-IP7921-Ag-2 Human KCNIP2 protein Human
GM-Tg-rg-IP7921-Ag-1/ GM-Tg-rg-IP7921-Ag-2 Rat KCNIP2 protein Rat
GM-Tg-mg-IP7921-Ag-1/ GM-Tg-mg-IP7921-Ag-2 Mouse KCNIP2 protein Mouse
GM-Tg-cynog-IP7921-Ag-1/ GM-Tg-cynog-IP7921-Ag-2 Cynomolgus/Rhesus macaque KCNIP2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7921-Ag-1/ GM-Tg-felg-IP7921-Ag-2 Feline KCNIP2 protein Feline
GM-Tg-cang-IP7921-Ag-1/ GM-Tg-cang-IP7921-Ag-2 Canine KCNIP2 protein Canine
GM-Tg-bovg-IP7921-Ag-1/ GM-Tg-bovg-IP7921-Ag-2 Bovine KCNIP2 protein Bovine
GM-Tg-equg-IP7921-Ag-1/ GM-Tg-equg-IP7921-Ag-2 Equine KCNIP2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7921-Ag-1/ GM-Tg-hg-IP7921-Ag-2; GM-Tg-rg-IP7921-Ag-1/ GM-Tg-rg-IP7921-Ag-2;
GM-Tg-mg-IP7921-Ag-1/ GM-Tg-mg-IP7921-Ag-2; GM-Tg-cynog-IP7921-Ag-1/ GM-Tg-cynog-IP7921-Ag-2;
GM-Tg-felg-IP7921-Ag-1/ GM-Tg-felg-IP7921-Ag-2; GM-Tg-cang-IP7921-Ag-1/ GM-Tg-cang-IP7921-Ag-2;
GM-Tg-bovg-IP7921-Ag-1/ GM-Tg-bovg-IP7921-Ag-2; GM-Tg-equg-IP7921-Ag-1/ GM-Tg-equg-IP7921-Ag-2
Products Name KCNIP2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name KCNIP2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KCNIP2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.